Partial nephrectomy versus ablative therapy for the treatment of renal tumors in an imperative setting
Cryoablation
Ablation Techniques
Male
[SDV]Life Sciences [q-bio]
Comorbidity
Imperative indication
Kidney
Cryosurgery
Disease-Free Survival
Congenital Abnormalities
03 medical and health sciences
0302 clinical medicine
616
Partial nephrectomy
Humans
Blood Transfusion
Carcinoma, Renal Cell
Aged
Length of Stay
Middle Aged
Kidney Neoplasms
3. Good health
[SDV] Life Sciences [q-bio]
Renal cancer
Radiofrequency
Multivariate Analysis
Catheter Ablation
Female
Kidney Diseases
Laparoscopy
Glomerular Filtration Rate
DOI:
10.1007/s00345-016-1913-4
Publication Date:
2016-08-06T15:24:33Z
AUTHORS (28)
ABSTRACT
To compare partial nephrectomy (PN) and percutaneous ablative therapy (AT) for renal tumor in imperative indication of nephron-sparing technique (NST).Between 2000 and 2015, 284 consecutive patients with a kidney tumor in an imperative indication of NST were retrospectively included in a multicenter study. PN [open (n = 146), laparoscopic (n = 9), or robotic approach (n = 17)] and AT [radiofrequency ablation (n = 104) or cryoablation (n = 8)] were performed for solitary kidney (n = 146), bilateral tumor (n = 78), or chronic kidney disease (CKD) (n = 60).Patients in the PN group had larger tumors and a higher RENAL score. There were no differences between the two groups with respect to age, reasons for imperative indication, and preoperative eGFR. Patients in the AT group had a higher ASA and CCI. PN had worse outcomes than AT in terms of transfusion rate, length of stay, and complication rate. Local radiological recurrence-free survival was better for PN, but metastatic recurrence was similar. Percentage of eGFR decrease was similar in the two groups. Temporary or permanent dialysis was not significantly different. On multivariate analysis, PN and AT had a similar eGFR change when adjusted for tumor complexity, reason of imperative indication and CCI.In imperative indication of nephron-sparing treatment for a kidney tumor, either PN or AT can be proposed. PN offers the ability to manage larger and more complex tumors while providing a better local control and a similar renal function loss.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (16)
CITATIONS (30)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....